These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 31070941)

  • 41. Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association.
    Warden BA; Guyton JR; Kovacs AC; Durham JA; Jones LK; Dixon DL; Jacobson TA; Duell PB
    J Clin Lipidol; 2023; 17(1):19-39. PubMed ID: 36115813
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statin intolerance.
    Ahmad Z
    Am J Cardiol; 2014 May; 113(10):1765-71. PubMed ID: 24792743
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An overview of statin-induced myopathy and perspectives for the future.
    Nikolic D; Banach M; Chianetta R; Luzzu LM; Pantea Stoian A; Diaconu CC; Citarrella R; Montalto G; Rizzo M
    Expert Opin Drug Saf; 2020 May; 19(5):601-615. PubMed ID: 32233708
    [No Abstract]   [Full Text] [Related]  

  • 44. Trial designs for statin muscle intolerance.
    Rosenson RS
    Curr Opin Lipidol; 2017 Dec; 28(6):488-494. PubMed ID: 28832369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decoding the Intricacies of Statin-Associated Muscle Symptoms.
    Rastegar TF; Khan IA; Christopher-Stine L
    Curr Rheumatol Rep; 2024 Jul; 26(7):260-268. PubMed ID: 38575845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Curcumin: An effective adjunct in patients with statin-associated muscle symptoms?
    Sahebkar A; Saboni N; Pirro M; Banach M
    J Cachexia Sarcopenia Muscle; 2017 Feb; 8(1):19-24. PubMed ID: 27897416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coenzyme Q10 as Treatment for Statin-Associated Muscle Symptoms-A Good Idea, but….
    Zaleski AL; Taylor BA; Thompson PD
    Adv Nutr; 2018 Jul; 9(4):519S-523S. PubMed ID: 30032220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Muscle pain and statin, pharmacological or nocebo effect?].
    Khouri C; Lepelley M; Mallaret M; Roustit M; Cracowski JL
    Therapie; 2018 Sep; 73(4):359-361. PubMed ID: 29366501
    [No Abstract]   [Full Text] [Related]  

  • 49. Statin myopathy: over-rated and under-treated?
    Maghsoodi N; Wierzbicki AS
    Curr Opin Cardiol; 2016 Jul; 31(4):417-25. PubMed ID: 27258372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Statin non-adherence and residual cardiovascular risk: There is need for substantial improvement.
    Banach M; Stulc T; Dent R; Toth PP
    Int J Cardiol; 2016 Dec; 225():184-196. PubMed ID: 27728862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient.
    Cheeley MK; Saseen JJ; Agarwala A; Ravilla S; Ciffone N; Jacobson TA; Dixon DL; Maki KC
    J Clin Lipidol; 2022; 16(4):361-375. PubMed ID: 35718660
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statin-associated muscle symptoms: position paper from the Luso-Latin American Consortium.
    Sposito AC; Faria Neto JR; Carvalho LS; Lorenzatti A; Cafferata A; Elikir G; Esteban E; Morales Villegas EC; Bodanese LC; Alonso R; Ruiz AJ; Rocha VZ; Faludi AA; Xavier HT; Coelho OR; Assad MH; Izar MC; Santos RD; Fonseca FA; Mello E Silva A; Silva PM; Bertolami MC;
    Curr Med Res Opin; 2017 Feb; 33(2):239-251. PubMed ID: 27776432
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Review of Statin Intolerance: a Focus on Statin-Attributed Muscle Symptoms.
    Orringer CE; Grant JK; Tokgozoglu L
    Curr Atheroscler Rep; 2022 Nov; 24(11):839-847. PubMed ID: 36001213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [How to cope with the nocebo effects of statins?].
    Lafeber M; Evers AWM; Klok FA
    Ned Tijdschr Geneeskd; 2023 Mar; 167():. PubMed ID: 36920298
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Statin-Associated Side Effects.
    Thompson PD; Panza G; Zaleski A; Taylor B
    J Am Coll Cardiol; 2016 May; 67(20):2395-2410. PubMed ID: 27199064
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statin-associated muscle symptoms in coronary patients: design of a randomized study.
    Munkhaugen J; Vethe NT; Fagerland MW; Dammen T; Perk J; Gjertsen E; Otterstad JE; Gullestad L; Bergan S; Husebye E
    Scand Cardiovasc J; 2019 Jun; 53(3):162-168. PubMed ID: 31030568
    [No Abstract]   [Full Text] [Related]  

  • 57. Statins in a Distorted Mirror of Media.
    Nelson AJ; Puri R; Nissen SE
    Curr Atheroscler Rep; 2020 Jun; 22(8):37. PubMed ID: 32557172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence of muscle symptoms in placebo arm among statin-intolerant patients: a systematic review with meta-analysis.
    Louro R; Gouveia E Melo R; Ruivo J; Almeida AG; Pinto FJ; Caldeira D
    Expert Rev Cardiovasc Ther; 2023; 21(11):887-894. PubMed ID: 37916684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of patients with statin intolerance.
    Martirossian AN; Goldberg AC
    Best Pract Res Clin Endocrinol Metab; 2023 May; 37(3):101714. PubMed ID: 36345572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimizing Cholesterol Treatment in Patients With Muscle Complaints.
    Rosenson RS; Baker S; Banach M; Borow KM; Braun LT; Bruckert E; Brunham LR; Catapano AL; Elam MB; Mancini GBJ; Moriarty PM; Morris PB; Muntner P; Ray KK; Stroes ES; Taylor BA; Taylor VH; Watts GF; Thompson PD
    J Am Coll Cardiol; 2017 Sep; 70(10):1290-1301. PubMed ID: 28859793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.